Comparative Evaluation of Visual Outcomes in Combined Cataract and Vitrectomy for Idiopathic Epiretinal Membrane with an Advanced or Conventional Intraocular Lens
Ophthalmic Research · 2024
DOI: 10.1159/000538316 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Ophthalmic Research, 2024. Verfasst von Se Hyun Choi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Hallym University Sacred Heart Hospital, Anyang-si, Republic of Korea. Hauptthemen laut MEDLINE: Vitrectomy, Visual Acuity, Epiretinal Membrane, Lenses, Intraocular. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
The aim of this study was to investigate the efficacy of new monofocal intraocular lens (IOL) in comparison with conventional monofocal IOL in patients undergoing combined cataract and vitrectomy surgery for epiretinal membrane (ERM).
Methods
This prospective non-randomized comparative study included 65 eyes of 65 patients who underwent combined cataract and vitrectomy for ERM with implantation of advanced monofocal IOL (Eyhance ICB00, 33 patients) and standard monofocal IOL (Tecnis ZCB00, 32 patients). Monocular visual acuities were measured 6 months post-operatively, including corrected and uncorrected distance visual acuity (CDVA, UCDVA), uncorrected intermediate visual acuity (UCIVA), and uncorrected near visual acuity (UCNVA). Furthermore, contrast sensitivity and metamorphopsia were measured.
Results
There was no significant difference between two groups regarding operation time, post-operative CDVA, UCDVA, UCNVA, and spherical equivalent (p > 0.05). Monocular UCIVA was significantly higher in the Eyhance IOL group than in the Tecnis IOL group (p = 0.005). The photopic and mesopic contrast sensitivities were comparable between each group for any spatial frequency (p > 0.05). The correlation coefficients from correlations between retinal wrinkling ratio and M score did not differ significantly between groups (p = 0.877), and the degree of metamorphopsia was not significantly related to the type of IOL (p = 0.969).
Conclusions
In combined cataract and vitrectomy for ERM, Eyhance IOL provided significant better visual performance at intermediate distance than standard monofocal IOL without compromising operation time, distance vision, contrast sensitivity, and evaluating metamorphopsia. Eyhance IOL can be a useful option for both surgeons and patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Hallym University Sacred Heart Hospital, Anyang-si, Republic of Korea.
- Department of Ophthalmology, College of Medicine, Soonchunhyang University, Cheonan-si, Republic of Korea.
- Dasan Samsung Bright Eye Clinic, Seoul, Republic of Korea.
- Seoul On Eye Clinic, Seoul, Republic of Korea.
- Department of Ophthalmology, Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.
- Department of Ophthalmology, Dongtan Sacred Heart Hospital, Hwaseong-si, Republic of Korea.
Zitieren
APA
Choi, S. H., Cho, I. H., Jeon, G. S., Chang, I. B., Ma, D. J., & Hong, I. H. (2024). Comparative Evaluation of Visual Outcomes in Combined Cataract and Vitrectomy for Idiopathic Epiretinal Membrane with an Advanced or Conventional Intraocular Lens. Ophthalmic Research. https://doi.org/10.1159/000538316
Vancouver
Choi SH, Cho IH, Jeon GS, Chang IB, Ma DJ, Hong IH. Comparative Evaluation of Visual Outcomes in Combined Cataract and Vitrectomy for Idiopathic Epiretinal Membrane with an Advanced or Conventional Intraocular Lens. Ophthalmic Research. 2024. doi:10.1159/000538316
BibTeX
@article{Choi2024,
author = {Choi, Se Hyun and Cho, In Hwan and Jeon, Gang Seok and Chang, In Boem and Ma, Dae Joong and Hong, In Hwan},
title = {Comparative Evaluation of Visual Outcomes in Combined Cataract and Vitrectomy for Idiopathic Epiretinal Membrane with an Advanced or Conventional Intraocular Lens},
journal = {Ophthalmic Research},
year = {2024},
doi = {10.1159/000538316}
}
EUVIMED